期刊
JOURNAL OF MATERIALS CHEMISTRY B
卷 8, 期 8, 页码 1649-1659出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c9tb02309g
关键词
-
资金
- Shriners Hospitals for Children Postdoctoral Fellowship [84705-NCA-19]
- UC Davis School of Medicine Dean's Fellowship
- NIH [5R01NS100761-02, R03HD091601-01]
- Shriners Hospitals for Children research grants [87200-NCA-19, 85108-NCA-19]
- March of Dimes Foundation Basil O'Connor Starter Scholar Research Award [5FY1682]
- UC Davis Comprehensive Cancer Center Support Grant - National Cancer Institute [P30CA093373]
Cell-biomaterial interactions are primarily governed by cell adhesion, which arises from the binding of cellular integrins to the extracellular matrix (ECM). Integrins drive the assembly of focal contacts that serve as mechanotransducers and signaling nexuses for stem cells, for example integrin alpha 4 beta 1 plays pivotal roles in regulating mesenchymal stem cell (MSC) homing, adhesion, migration and differentiation. The strategy to control the integrin-mediated cell adhesion to bioinspired, ECM-mimicking materials is essential to regulate cell functions and tissue regeneration. Previously, using one-bead one-compound (OBOC) combinatorial technology, we discovered that LLP2A was a high-affinity peptidomimetic ligand (IC50 = 2 pM) against integrin alpha 4 beta 1. In this study, we identified that LLP2A had a strong binding to human early gestation chorionic villi-derived MSCs (CV-MSCs) via integrin alpha 4 beta 1. To improve CV-MSC seeding, expansion and delivery for regenerative applications, we constructed artificial scaffolds simulating the structure of the native ECM by immobilizing LLP2A onto the scaffold surface as cell adhesion sites. LLP2A modification significantly enhanced CV-MSC adhesion, spreading and viability on the polymeric scaffolds via regulating signaling pathways including phosphorylation of focal adhesion kinase (FAK), and AKT, NF-kB and Caspase 9. In addition, we also demonstrated that LLP2A had strong binding to MSCs of other sources, such as bone marrow-derived mesenchymal stem cells (BM-MSCs) and adipose tissue-derived mesenchymal stem cells (AT-MSCs). Therefore, LLP2A and its derivatives not only hold great promise for improving CV-MSC-mediated treatment of fetal diseases, but they can also be widely applied to functionalize various biological and medical materials, which are in need of MSC recruitment, enrichment and survival, for regenerative medicine applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据